BSX Boston Scientific Corporation Common Stock

NYSE · US · Healthcare · Medical Devices · bostonscientific.com

42.51USD-0.20%Mkt Cap: 61.74B $P/E: 17.25Today

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offe…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap61.74B USD

Enterprise Value74.06B USD

Revenue (TTM)21.00B USD

Gross Profit13.85B USD

Net Income (TTM)2.90B USD

Revenue/Share14.19 USD

Last Price42.51 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees59.0K

CountryUS

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)17.25

P/E (Forward)12.49

PEG0.60

EV/EBITDA12.97

EV/Revenue3.53

P/S2.94

P/B2.47

EPS (TTM)2.47

EPS (Forward)3.41

52W Range

41.941% of range105.65

52W High105.65 USD

52W Low41.94 USD

Profitability

Gross Margin69.01%

Oper. Margin22.90%

EBITDA Margin27.20%

Profit Margin14.44%

ROE11.96%

ROA6.64%

Growth

Revenue Growth7.50%

Earnings Growth15.10%

Cash Flow & Leverage

Operating CF4.53B USD

CapEx (TTM)1.13B USD

FCF Margin11.68%

FCF Yield3.97%

Net Debt12.09B USD

Net Debt/EBITDA2.12

Balance Sheet

Debt/Equity0.47

Current Ratio1.24

Quick Ratio0.56

Book Value/Sh17.23 USD

Cash/Share0.37 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split2:1

Split DateNov 6, 2003

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)60.79 USD

Upside (mean)+43.0%

Target Range44.00 USD – 94.00 USD

44.00+43.0% to mean94.00

# Analysts29

Ownership

Shares Out.1.45B

Float1.44B

Insiders0.25%

Institutions95.11%

Short Interest

Short Ratio2.3d

Short % Float3.21%

Short % Out.3.21%

Shares Short46.50M

Short (prev mo.)27.62M

Technical

SMA 5046.88 (-9.3%)

SMA 20061.73 (-31.1%)

Beta0.57

S&P 52W Chg14.58%

Avg Vol (30d)20.10M

Avg Vol (10d)18.77M

Technical Indicators

RSI (14)35.8

MACD-0.9795

MACD Signal-0.9570

MACD Hist.-0.0225

BB Upper46.39 USD

BB Middle44.14 USD

BB Lower41.90 USD

BB Width10.19%

ATR (14)1.368 USD

Vol Ratio (20d)0.88x